224 related articles for article (PubMed ID: 27656601)
21. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
22. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
Zhao M; Zhou ZT
Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
[TBL] [Abstract][Full Text] [Related]
23. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.
Aslani N; Janbabaei G; Abastabar M; Meis JF; Babaeian M; Khodavaisy S; Boekhout T; Badali H
BMC Infect Dis; 2018 Jan; 18(1):24. PubMed ID: 29310582
[TBL] [Abstract][Full Text] [Related]
24. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP
Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094
[TBL] [Abstract][Full Text] [Related]
26. Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant
Locke JB; Almaguer AL; Donatelli JL; Bartizal KF
Infect Dis Obstet Gynecol; 2018; 2018():7040498. PubMed ID: 29681727
[TBL] [Abstract][Full Text] [Related]
27. Oral Candida isolates and fluconazole susceptibility patterns in older Mexican women.
Benito-Cruz B; Aranda-Romo S; López-Esqueda FJ; de la Rosa-García E; Rosas-Hernández R; Sánchez-Vargas LO
Arch Gerontol Geriatr; 2016; 65():204-10. PubMed ID: 27088219
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
[TBL] [Abstract][Full Text] [Related]
29. Oral Candida isolates among HIV-infected subjects in Nigeria.
Nweze EI; Ogbonnaya UL
J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
[TBL] [Abstract][Full Text] [Related]
30. Colonization of voice prostheses by albicans and non-albicans Candida species.
Bauters TG; Moerman M; Vermeersch H; Nelis HJ
Laryngoscope; 2002 Apr; 112(4):708-12. PubMed ID: 12152601
[TBL] [Abstract][Full Text] [Related]
31. Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis.
Song YB; Suh MK; Ha GY; Kim H
Ann Dermatol; 2015 Dec; 27(6):715-20. PubMed ID: 26719641
[TBL] [Abstract][Full Text] [Related]
32. Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran.
Maheronnaghsh M; Fatahinia M; Dehghan P; Teimoori A
Adv Biomed Res; 2020; 9():50. PubMed ID: 33457333
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
34. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
35. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
Wang JL; Chang SC; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2004 Aug; 37(4):236-41. PubMed ID: 15340652
[TBL] [Abstract][Full Text] [Related]
36. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.
Troillet N; Durussel C; Bille J; Glauser MP; Chave JP
Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):911-5. PubMed ID: 8187785
[TBL] [Abstract][Full Text] [Related]
37. Oral candidal speciation, virulence and antifungal susceptibility in type 2 diabetes mellitus.
Patel PN; Sah P; Chandrashekar C; Vidyasagar S; Venkata Rao J; Tiwari M; Radhakrishnan R
Diabetes Res Clin Pract; 2017 Mar; 125():10-19. PubMed ID: 28131069
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
[TBL] [Abstract][Full Text] [Related]
39. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
Yücesoy M; Marol S
Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
[TBL] [Abstract][Full Text] [Related]
40. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.
Basso V; Garcia A; Tran DQ; Schaal JB; Tran P; Ngole D; Aqeel Y; Tongaonkar P; Ouellette AJ; Selsted ME
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
